Pyxis Oncology Inc (PYXS)
4.165
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
4.165
0.00 (0.00%)
After-Hours: 20:00
Pyxis Oncology Shareholders Equity (Quarterly): 184.16M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 184.16M |
| December 31, 2023 | 125.70M |
| September 30, 2023 | 137.95M |
| June 30, 2023 | 145.28M |
| March 31, 2023 | 152.16M |
| December 31, 2022 | 160.82M |
| September 30, 2022 | 188.75M |
| Date | Value |
|---|---|
| June 30, 2022 | 211.97M |
| March 31, 2022 | 233.51M |
| December 31, 2021 | 261.31M |
| September 30, 2021 | -71.44M |
| June 30, 2021 | -57.59M |
| December 31, 2020 | -15.64M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-71.44M
Minimum
Sep 2021
261.31M
Maximum
Dec 2021
127.46M
Average
152.16M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| Apyx Medical Corp | 20.25M |
| Nortech Systems Inc | 36.01M |
| Phio Pharmaceuticals Corp | 5.604M |
| X4 Pharmaceuticals Inc | 1.036M |
| Monogram Orthopaedics Inc | 10.23M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 220.22M |
| Total Liabilities (Quarterly) | 36.06M |
| Current Ratio | 12.19 |